Literature DB >> 6196639

A shared antigenic determinant between natural killer cells and nervous tissue.

S Schuller-Petrovic, W Gebhart, H Lassmann, H Rumpold, D Kraft.   

Abstract

Considerable evidence for shared antigenic determinants between nervous elements and lymphocytes has accumulated. It has also been suggested that this cross-recognition may be involved in the pathogenesis of human neurological diseases such as myasthenia gravis and multiple sclerosis. We report here evidence that a marker for natural killer (NK) cells, anti-Leu-7 (HNK-1), specifically binds to components of human and rodent central nervous tissue as well as peripheral nervous tissue, especially to myelin sheaths. In contrast, another NK-cell marker (VEP13) did not react with nervous tissue. Since NK-cell function is impaired in a population of multiple sclerosis patients, the observed cross-reactivity indicates that autosensitization against myelin may simultaneously cause a defect of NK-cell function. Furthermore, the shared antigenic determinant may help to identify a hitherto undefined nervous tissue antigen and simultaneously increase the knowledge about the nature of NK-cell antigens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196639     DOI: 10.1038/306179a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  56 in total

1.  Tonsillar mapping of determinants found on normal lymphoreticular (T,B,K, immature and macrophage) and myeloblastic leukemia cells.

Authors:  E M McMillan; L Stoneking; G B Humphrey; J Rapacz
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

2.  Distribution of anti-Leu-7, anti-Leu-11a and anti-Leu-M1 immunoreactivity in the brain of the adult rat.

Authors:  G Reifenberger; J K Mai; S Krajewski; W Wechsler
Journal:  Cell Tissue Res       Date:  1987-05       Impact factor: 5.249

3.  Adrenocortical cells of the zona reticularis normally express HLA-DR antigenic determinants.

Authors:  E L Khoury; J S Greenspan; F S Greenspan
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

Review 4.  Monoclonal antibodies to myelin-associated glycoprotein reveal antigenic structures and suggest pathogenic mechanisms.

Authors:  A J Steck; N Murray
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Myelin-associated glycoprotein in neurogenic tumours of the skin: an immunohistological study using Leu-7 monoclonal antibody.

Authors:  J Smolle; G F Walter; H Kerl
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  Involvement of brain opiate receptors in the immune-suppressive effect of morphine.

Authors:  Y Shavit; A Depaulis; F C Martin; G W Terman; R N Pechnick; C J Zane; R P Gale; J C Liebeskind
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood.

Authors:  M J Dobersen; P Gascon; S Trost; J A Hammer; S Goodman; A B Noronha; D J O'Shannessy; R O Brady; R H Quarles
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  Herpes simplex virus-enhanced production of autoantibodies against myelin basic protein in mice.

Authors:  S Gudmundsdottir; B Svennerholm; K Kristensson; E Lycke
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 9.  Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system--a review.

Authors:  F B Jungalwala
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

10.  Non-specific binding of mouse myeloma IgM immunoglobulins by human myelin sheaths and astrocytes. A potential complication of nervous system immunoperoxidase histochemistry.

Authors:  E Perentes; L J Rubinstein
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.